Today, Austin discusses the potential for pharmaceutical giant Walgreen (WBA 0.04%). The company's dividend and wide-ranging store basis give it a promising base network, but it still faces an uphill battle. Competitor CVS uses its own PBM, and the Express Scripts fallout continues to plague Walgreen. The recent Boots purchase will make it even harder for the company to shore up domestic issues, and it will struggle to grow unless a company like Rite Aid goes under and surrenders market share. Austin remains bearish on Walgreen and rates it as a definite sell. If you're interested in some of these dividends on your quest for high-yielding stocks, The Motley Fool has compiled a special free report outlining our nine top dependable dividend-paying stocks. It's called "Secure Your Future With 9 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost! Just click here to discover the winners we've picked.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Buy, Sell, or Hold Walgreen?
NASDAQ: WBA
Walgreens Boots Alliance

About the Author
A long-term investor looking to own the best businesses available.
Austin Smith has no positions in the stocks mentioned above. The Motley Fool owns shares of Express Scripts. Motley Fool newsletter services recommend Express Scripts. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned




*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.